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sleep disorders among Egyptian children with chronic kidney disease (CKD), either maintained
or not maintained on hemodialysis (HD), and compared them with healthy age and sex-
matched children.
Patients and methods: The total study population included 95 children, 54 of whom were CKD
patients, 22 maintained on HD and 32 not maintained on HD; 41 healthy children of matched
age and sex composed the control group.
Subjective impairment of sleep quality was assessed using the Arabic version of the Children’s
Sleep Habits Questionnaire (CSHQ). Daytime sleepiness and restless leg syndrome (RLS) were
assessed using a pediatric modification of the Epworth sleepiness scale (ESS) and RLS Question-
naire, respectively.
Results: Sleep disturbances were detected in 75.9% of the studied children with CKD: 81.8% in
children with CKD undergoing dialysis, and 71.8% in children with CKD not on dialysis. Excessive
daytime sleepiness (EDS) and RLS symptoms were reported in 22% and 20.4% of the studied chil-
dren with CKD, respectively.
Conclusions: Sleep disturbances are very common among children with CKD. Sleep distur-
bances in patients with CKD include restless legs syndrome (RLS), excessive daytime sleepiness
(EDS), sleep-disordered breathing (SDB), behavioral insomnias, and parasomnias.
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An adequate amount and quality of sleep are essential for
normal growth, development, and overall health of chil-
dren. Disturbed sleep can adversely affect a child’s daytime
function, resulting in behavioral and emotional problems as
well as decrements in daytime alertness and cognitive
performance [1].
Sleep disorders are important but often overlooked
health problem in children with chronic kidney disease
(CKD) [2]. To date, a small number of studies have focused
on sleep disturbances in children with CKD. Additionally,
the underlying mechanisms of sleep problems in CKD
remain unclear. The aim of this study was to assess the
prevalence and risk factors of sleep disorders among
Egyptian children with chronic kidney disease (CKD), either
maintained or not maintained on hemodialysis (HD), and to
compare them with healthy children.
2. Patients and methods
The study was approved by the Institutional Review Board
of Faculty of Medicine, Tanta University, and informed
consent was obtained from all participants prior to
inclusion.
The total study population included 95 patients, 54 of
whom were CKD patients; 22 patients were maintained on
HD, and 32 patients were not maintained on HD. Another 41
healthy children of matched age and sex served as the
control group. Participants were recruited from the
outpatient nephrology clinic and hemodialysis unit in the
Department of Pediatrics, Faculty of Medicine, Tanta Uni-
versity Hospital, AlGharbia, Egypt from June 2014 to
September 2015.
Children younger than 6 years of age were excluded, as
they could not reliably comprehend the questionnaire
about RLS. Children on sedative or hypnotic medications or
suffering from any other chronic illness were also excluded.
The stages of CKD were determined based on the eGFR
using the Schwartz formula [3].
National Kidney Foundation Disease Outcomes Quality
Initiative (K/DOQI) CKD stages: [4]
1. Stage 1: eGFR  90 mL/min/1.73 m2
2. Stage 2: eGFR Z 60e89 mL/min/1.73 m2
3. Stage 3: eGFR Z 30e59 mL/min/1.73 m2
4. Stage 4: eGFR Z 15e29 mL/min/1.73 m2
5. Stage 5: eGFR < 15 mL/min/1.73 m2, or receiving
dialysis.
Subjective impairment of sleep quality was assessed using
the Children’s Sleep Habits Questionnaire (CSHQ) [5]. The
children’s mothers completed the Arabic version of the CSHQ
[6]. The CSHQ was translated, modified, and validated for
this population and culture. It is a retrospective, 33-item
parent questionnaire grouped into eight subscales reflecting
the following sleep domains: bedtime resistance (5 items),
sleep onset delay (1 item), sleep duration (3 items), sleep
anxiety (3 items), night waking (3 items), parasomnias
(7 items), sleep-disordered breathing (3 items), and daytime
sleepiness (8 items) [7].The total sleep disturbance score included all of the
items from the eight subscales; the parents were asked to
recall sleep behaviors occurring over a “typical” recent
week. Items were rated on a three-point scale: “usually” if
the sleep behavior occurred 5e7 times/week, “sometimes”
2e4 times/week, and “rarely” for zero to one time/week.
Each question was scored from 1 to 3, (one being rarely, 2
being sometimes, and 3 being usually) and then summed to
create a total sleep score (with the total ranging from 33 to
99). Some items were reversed to make a higher score
indicative of more disturbed sleep. Higher scores indicated
a poorer quality of sleep. A total sleep score of 41 on the
CSHQ is reported as the clinical cutoff for the identification
of probable sleep problems [5].
A pediatric modification of the Epworth sleepiness scale
(ESS) was used to assess daytime sleepiness, in which sub-
jects were asked to rate on a scale of 0e3, how likely they
would be to fall asleep in eight situations [8]. Excessive
daytime sleepiness (EDS) was defined as an ESS score  11.
The restless leg syndrome (RLS) Questionnaire, derived
from the standard criteria for the diagnosis of RLS in chil-
dren and adolescents [9], was administered to determine
the prevalence of RLS. Patients were given a positive
diagnosis of RLS if they had a positive response to four
standard questions: (1) an urge to move due to uncom-
fortable sensations in the legs, (2) uncomfortable sensa-
tions that are relieved by movement, (3) symptoms worsen
during rest or inactivity, and (4) symptoms worsen in the
evening. The questionnaire was filled out by the parent in
the presence of the child for children aged 6e12 years and
independently by older children and adolescents.
2.1. Statistical analysis
Descriptive statistics were calculated as the mean  SD for
continuous variables and as numbers and percentages for
categorical variables using SPSS V.16. Group differences
were tested using the chi-square test for categorical vari-
ables and one-way ANOVA for continuous variables. ANOVA
was followed by a Tukey HSD (Honestly Significant Differ-
ence) post hoc test. Correlation coefficients and linear and
logistic regression models were used to evaluate the asso-
ciation between sleep disturbance and variables such as
age, BMI, and eGFR. All tests were two-sided, and differ-
ences were considered to be significant at P < .05.
3. Results
Studied groups’ characteristics and demographic data are
presented in Table 1. The total study population included
95 patients, with 54 CKD patients, 22 patients maintained
on HD (n 22; M/F 12:10) and 32 CKD patients not maintained
on HD (n 32; M/F 19:13); 41 healthy children of matched
age and sex served as a control group (n 41; M/F 23:18). End
stage renal disease (ESRD) patients were undergoing regular
HD three times/week for 3e4 h using bicarbonate dialysis
to maintain a minimum Kt/V index of 1.2 per session.
The studied groups’ laboratory data are presented in
Table 2. Serum creatinine, hemoglobin, calcium, and
phosphorus were significantly higher in CKD children on
hemodialysis compared to nonedialysis-dependent CKD
Table 1 Studied groups’ characteristics and demographic data.
Parameters Group 1
CKD-dialysis patients
Group 2
CKD-non-dialysis patients
Group 3
Healthy controls
P value
Number 22 32 41
Sex (Male/Female) 12/10 19/13 23/18 .86
Male (%) 54.5 59.3 56.1
Age (years) Mean (SD) 10.70 (2.83) 9.31 (2.71) 9.64 (3.43) .25
Weight (kg) Mean (SD) 26.93 (11.64) 29.87 (9.66) 33.26 (13.03) .20
BMI Mean (SD) 16.83 (3.44) 18.68 (2.99) 19.15 (3.62) .24
Height (cm) Mean (SD) 124.60 (17.68) 126.30
(14.45)
129.27 (16.83) .36
Estimated GFR (ml/min/1.73 m2) Mean (SD) 10.69 (2.33) 82.08 (17.83) 103.80 (8.07) <.001
Duration of HD (months) Mean (SD)
Kt/V Mean (SD)
26.77 (25.87)
1.13 (0.085)
CKD: Chronic kidney disease, BMI: Body mass index, GFR: Glomerular filtration rate, HD: Hemodialysis.
Table 2 Studied groups’ laboratory data.
Parameters Group 1
CKD-dialysis patients
Group 2
CKD-non-dialysis patients
Group 3
Healthy controls
P value
Creatinine (mg/dL) Mean (SD) 5.92 (1.16) 0.97 (0.19) 0.64 (0.12) <.001
Hemoglobin (g/dL) Mean (SD) 10.45 (1.44) 11.26 (0.87) 12.00 (0.81) <.001
Total Ca (mg/dL) Mean (SD) 9.65 (0.89) 10.17 (0.57) 10.41 (0.46) <.001
P (mg/dL) Mean (SD) 5.35 (0.75) 4.29 (0.47) 4.33 (0.59) <.001
Ca: Total serum calcium, P: Serum phosphorus.
Figure 2 Causes of CKD in non-dialysis patients.
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significant difference between nonedialysis-dependent
CKD children and controls (P > .05).
Figs. 1 and 2 show the causes of CKD in the studied
children. Glomerulonephritis was the most common cause,
accounting for 45.4% in dialysis-dependent and 68.7% in
non-dialysis-dependent children with CKD. Fig. 3 displays
the stages of CKD in non-dialysis-dependent CKD patients;
62.5% of the studied non-dialysis-dependent CKD patients
had Stage 2 disease.
The Children’s Sleep Habits Questionnaire (CSHQ) total
and subscale scores are presented in Table 3. The total
CSHQ scores were significantly higher in both groups of CKD
children compared to controls (P < .05), while no significantFigure 1 Causes of CKD in dialysis patients. Figure 3 Stages of CKD in non-dialysis patients.
Table 3 The Children’s Sleep Habits Questionnaire (CSHQ): total and subscales scores in the studied groups.
CSHQ subscales scores
(Rang, mean(SD)
Group 1
CKD-dialysis patients
Group 2
CKD-non-dialysis patients
Group 3
Healthy controls
P value
1. Bedtime resistance 6e14
9.45 (2.06)
6e12
8.06 (2.29)
6e8
6.02 (0.93)
<.001
2. Sleep onset delay 1e3
2.45 (0.59)
1e3
1.5 (0.56)
1e2
1.14 (0.35)
<.001
3. Sleep anxiety 4e9
5.31 (1.76)
4e7
5.12 (1.38)
4e6
3.78 (0.68)
<.001
4. Sleep duration 3e8
5.4 (1.4)
4e7
5.12 (0.83)
3e6
4.04 (0.86)
<.001
5. Night waking 3e7
5.03 (1.37)
3e6
4.27 (0.98)
3e5
4.0 (0.77)
<.001
6. Parasomnias 7e16
11.40 (2.51)
7e13
9.65 (1.71)
7e10
8.41 (0.77)
<.001
7. Sleep-disordered breathing 3e6
4.2 (0.71)
3e4
3.53 (0.50)
3e4
3.31 (0.47)
.036
8. Daytime sleepiness 10e22
14.77 (3.95)
8e15
10.93 (1.91)
8e12
8.97 (0.93)
<.001
CSHQ Total scores 41e78
54.81 (9.45)
35e64
50.18 (7.98)
34e48
39.70 (4.31)
<.001
CSHQ score >41
n (%)
18 (81.8%) 23 (71.8%) 8 (19.5%) <.001
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dialysis and nonedialysis-dependent patients (P Z .054).
Approximately 75.9% of the studied children with CKD
scored above the CSHQ clinical cutoff score for disordered
sleep: 81.8% in dialysis patients and 71.8% in non-dialysis
patients.
The sleep duration and sleep anxiety scores on the CSHQ
were significantly higher in both groups of CKD children
compared to controls (P < .05), while no significant dif-
ference was observed between CKD children on hemodial-
ysis and nonedialysis-dependent CKD patients (P > .05).
The subscale scores of bedtime resistance, sleep onset
delay, daytime sleepiness, and parasomnia were signifi-
cantly higher in CKD children on hemodialysis than in non-
edialysis-dependent CKD children (P < .05), while both
groups of children with CKD had scores significantly higher
than controls (P < .05). Sleep-disordered breathing and
night waking were significantly higher in CKD children on
hemodialysis compared to nonedialysis-dependent CKD
children and controls (P < .05). However, no significantTable 4 The Epworth sleepiness scale (ESS) scores of the studi
ESS scores Group 1
CKD-dialysis patients
Group 2
CKD-non-di
Range 5e18 3e14
Mean (SD) 11.72 (3.48) 7.25 (2.67)
ESS score  11
n (%) 10 (45.5%) 2 (6.25%)
Total n 22 32difference was observed between nonedialysis-dependent
CKD children and controls (P > .05).
The Epworth sleepiness scale (ESS) results of the stud-
ied groups are presented in Table 4. The ESS score was
significantly higher in CKD children on hemodialysis
compared to those not on dialysis (P < .05). Both groups of
CKD children had ESS scores that were significantly higher
than those of controls (P < .05). An ESS score 11 was
reported in 22% of the studied children with CKD: 45.5% in
dialysis patients and 6.25% in non-dialysis patients
compared to 2.4% of the children in the control group. EDS
was significantly more prevalent in the in dialysis patients
(P < .001).
The RLS symptoms in the studied groups are presented in
Table 5. RLS symptoms were reported in 20.4% of the
studied children with CKD: 36.4% in dialysis patients and
9.4% in non-dialysis patients. RLS symptoms were reported
in only 2.4% of the children in the control group. The
prevalence of RLS was significantly higher in the in dialysis
patients (P < .001).ed groups.
alysis patients
Group 3
Healthy controls
P value
2e14
5.07 (2.47) <.001
1 (2.4%) <.001
41
Table 5 Restless legs syndrome (RLS) symptoms in the studied groups.
RLS
n (%)
Group 1
CKD-dialysis patients
Group 2
CKD-non-dialysis patients
Group 3
Healthy controls
P value
Yes 8 (36.4%) 3 (9.4%) 1 (2.4%)
No 14 (63.6) 29 (90.6%) 40 (97.6%) <.001
Total 22 32 41
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demographic and laboratory data in children with
CKD
There was a significant negative correlation between CSHQ
scores and eGFR (rZ 0.28, PZ .04) and Ca (rZ 0.384,
P Z .004), with no significant correlation between the
score and age (r Z 0.7, P Z .5), BMI (r Z 0.158,
P Z .125), or Hb (r Z 0.23, P Z .089). There was a sig-
nificant positive correlation between serum phosphorus
(r Z 0.52, P < .001) and CSHQ scores.
Linear regression revealed a significant positive associ-
ation between the serum phosphorus and CSHQ scores;
every increase in serum P by 1 mg/dL was associated with
an increase in CSHQ scores by 6.865. A significant negative
association was found between the GFR and CSHQ scores, a
decrease in GFR by 10 ml/min/1.73 m2 was associated with
an increase in CSHQ scores by 0.65. Linear regression
revealed no significant association between CSHQ and age,
BMI, Hb, or Ca.
There was a significant positive correlation between the
ESS score and serum P (r Z 0.6, P < .001) and serum
creatinine (rZ 0.555, P < .001), with a significant negative
correlation between the ESS score and GFR (r Z 0.659,
P < .001), with no significant correlation between the ESS
score and age, Hb or BMI. Linear regression revealed a
significant negative association between GFR and ESS.
Every decrease in GFR by 1 ml/min/1.73 m2 was associated
with an increase of 0.079 in ESS. Linear regression revealed
no significant association between ESS and age, Hb, BMI, or
serum phosphorus.
Logistic regression revealed a significant negative asso-
ciation between GFR and RLS (P < .05); a decrease in GFR
by 1 ml/min/1.73 m2 was associated with an increase in the
probability of RLS by 49%. No association was observed
between RLS and other variables, e.g., age, Hb, serum Ca,
or serum phosphorus.
4. Discussion
In the present study, symptoms of sleep disturbances were
detected in 75.9% of the studied children with CKD and in
19.5% of the normal children in the control group. Sleep
disturbances were more frequent in the hemodialysis group
compared with non-dialysis CKD patients, with a prevalence
of 81.8% in hemodialysis patients and 71.8% in non-dialysis
patients.
The high prevalence of sleep disturbances in our study is
similar to that reported in previous studies among children
with CKD; sleep disorders were reported in 32%e85% of
children with CKD [10e14]: 77e85% in dialysispatients [10,11,14], and 32e50% in non-dialysis patients
[11e13].
Sleep disturbances detected in our patients with CKD
included RLS, EDS, sleep-disordered breathing (SDB),
behavioral insomnias, and parasomnias. Bedtime resistance,
sleep onset delay, daytime sleepiness, and parasomnia were
more reported in hemodialysis-dependent than non-dialysis-
dependent CKD children; both groups had higher scores than
the control group. Children with CKD displayed more sleep
anxiety and shorter sleep duration thannormal children,with
no difference between hemodialysis and nonedialysis-
dependent CKD children.
We observed SDB and night waking in HD patients, but not
in nonedialysis-dependent CKD children. Both pediatric and
adult studies have shown that SDB is common among
advanced CKD (stages 4e5) and HD patients [10,11,14e16].
The non-dialysis-dependent CKD children in our study did not
include stage IV CKD because of the lack of a transplantation
program at Tanta University Hospital; therefore, most stage
IV CKD patients are followed in other centers for preemptive
transplantation. Furthermore, stage III CKD was observed in
our study in only 12.5% of non-dialysis-dependent children,
which may explain why SDB was not reported in our patients
with non-dialysis-dependent CKD. Similarly, Sinha et al [12]
reported SDB in only 6% of nonedialysis-dependent CKD
children; most of the children studied were stage 1 and 2,
while stage 4 was observed in only 2%.
We reported EDS in 22% of the studied children with CKD,
with a prevalence of 45.5% in dialysis patients and 6.25% in
non-dialysis patients. EDS was reported in only 2.4% of the
children in the control group. RLS symptoms were detected
in 20.4% of the studied children with CKD: 36.4% in dialysis
patients and 9.4% in non-dialysis patients. RLS symptoms
were reported in only 2.4% of the control group.
Our findings are consistent with those of previous studies
among children with CKD; EDS symptoms were reported in
29e60% of children with CKD: 60% in dialysis patients
[10,11,14] and 29e39.7% in non-dialysis patients [11,17].
RLS symptoms were reported in 10%e35% of children with
CKD [14,17,18].
The prevalence of sleep disorders among adults with
CKD ranges from 40% to 80% [19e21], and RLS symptoms are
reported in 20%e40% of adult patients with CKD [22e24].
The variation in prevalence of sleep disturbances in
children with CKD between the studies is likely due to
different populations being studied, either dialysis-
dependent or non-dialysis-dependent; differences be-
tween the number of studied subjects; the method of
diagnosis of sleep disorders, whether based on question-
naires or polysomnography (PSG); and the type of ques-
tionnaire used to assess sleep disturbances. Sinha et al [12]
and Roumelioti et al [13] reported disordered sleep in 37%
Sleep disorders in children 117and 12% of the studied CKD children, respectively. The
lower prevalence of sleep problems in these studies may be
related to under-detection of sleep problems due to not
using validated sleep questionnaires. In addition, those
authors studied only non-dialysis-dependent CKD children
and did not include dialysis patients.
Behavioral sleep problems (i.e., bedtime resistance,
sleep onset delay, shorter sleep duration, and night awak-
enings) were observed among children with CKD in our
study, suggesting that behavioral and psychological factors
may contribute to the occurrence of sleep problems among
children with CKD. Depression and anxiety have been
documented as major determinants of sleep quality and
disturbances in adult populations with CKD [25]. Adult
studies have suggested that the etiologies of sleep prob-
lems in patients with CKD and those on chronic intermittent
daytime hemodialysis are different. Functional and psy-
chological factors may play a more prominent role in the
non-dialysis-dependent CKD group, while intrinsic sleep
disruption (arousals, apneas, and limb movements) sec-
ondary to the effects of chronic intermittent dialysis may
play a more significant role in the dialysis population. This
postulated different mechanism may explain the presence
of sleep disorders in patients with early CKD [26] in which
psychosocial factors could be important contributors.
4.1. Associations between CKD-related factors and
sleep disorders
We found a significant positive association between the
serum phosphorus and CSHQ scores and a significant nega-
tive association between the GFR and CSHQ scores, sug-
gesting that lower GFR and hyperphosphatemia are risk
factors for sleep disturbances in children with CKD.
Consistent with our study, the positive association between
sleep disturbances and hyperphosphatemia in CKD has been
documented in a number of adult studies [27e29]. In
contrast to our findings, Sinha et al [12] found no correla-
tion between the stage of CKD and the prevalence of sleep
problems; they did not observe any differences in the
incidence of sleep disorders across the stages of CKD.
Additionally, lower GFR was associated with increased
RLS and EDS in our study. Similarly, Roumelioti et al [13]
found that lower GFR in pediatric CKD patients was asso-
ciated with increased daytime sleepiness. In contrast, Riar
et al [18] reported that RLS was more prevalent in adoles-
cents, but he found no significant association between
sleep symptoms and CKD stage.
Several uremic and non-uremic factors may explain the
relatively high frequency of sleep problems in children with
CKD. The increased prevalence of sleep disorders in CKD
children undergoing dialysis suggests that the dialysis pro-
cedure may be a factor in sleep disorders by causing
insufficient sleep. In addition, metabolic factors, including
uremia, hyperphosphatemia, hyperparathyroidism, and
iron status, can affect sleep in CKD patients [27e30]. Low
production of melatonin and circadian rhythm disruption
observed in patients with chronic renal failure may also be
causative factors for sleep disturbances [31,32].
Congenital abnormalities, such as renal hypoplasia or
dysplasia, and obstructive uropathy represent the mostcommon causes of CKD in children younger than 5 years of
age. While in CKD children older than 5 years of age, ac-
quired diseases, such as glomerulonephritis, and inherited
disorders, such as hereditary nephropathies predominate
[33]. In our study, we excluded children less than 6
years of age, as they could not reliably comprehend the
questionnaire about RLS, which may explain why glomeru-
lonephritis was the most common cause of CKD in our
studied patients.
There were limitations in this study. The questionnaire
results were not corroborated with objective measure-
ments of sleep disturbances, such as polysomnography. A
second problem was the small sample size. Therefore,
future studies should incorporate multi-site patients, using
both subjective and objective measures such as poly-
somnography for assessing sleep disorders in children with
CKD.
A strength of our study is that we studied both non-
dialysis and dialysis-dependent children with CKD; conse-
quently, we were able to compare the prevalence of sleep
disorders across the full spectrum of chronic kidney dis-
ease. In addition, the study was a case-control study
allowing comparisons with age and sex-matched healthy
children as controls. Furthermore, the diagnosis of sleep
disorders was based on structured interviews using a vali-
dated sleep questionnaire.
5. Conclusion
Sleep disturbances are very common in children with CKD
compared to healthy children. Sleep disturbances in pa-
tients with CKD include restless legs syndrome (RLS),
excessive daytime sleepiness (EDS), sleep-disordered
breathing (SDB), behavioral insomnias, and parasomnias.
Therefore, it is important for practitioners caring for chil-
dren with CKD to anticipate and screen for treatable sleep
disorders. Early recognition and treatment of sleep distur-
bances may have a positive impact on the growth and
development of children with CKD.
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